Health Condition 1: null- Mild to Moderate Knee Osteoarthritis
Conditions
Interventions
Intervention1: Actitape: ActiTape or knee guard group in ratio of 1:1 at Baseline. Patients would continue using ActiTape or knee guard for a period of 6 days. This would be followed by a wash-out f
Sponsors
Nutriworks Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Ambulatory adult patients of either sex aged 30-65 years. 2. Patients with moderate OA of the knee, which can be clinically, categorized as ARA functional Class II and III and with radiological confirmation of Kellgren Lawrence Grade II and III. 3. Patientâ??s functional assessment of overall pain score should be >= 50 mm on a 100 mm VAS for pain at baseline visit. 4. Patients receiving a stable dose of oral calcium or chondrogenic supplements for at least past 1 month and/or a stable dose of NSAIDs for the past 1 week will be eligible for inclusion
Exclusion criteria
Exclusion criteria: 1. Patients of any form of arthritis other than osteoarthritis. 2. Arthroscopy of either knee in the past year. 3. Administration of intra-articular or oral steroids in the past 3 month or intra articular hyaluronic acid in the last 9 months or parenteral use of NSAIDs. 4. Patients requiring immediate surgery for knee. 5. Pregnant / lactating women and women who are planning to get pregnant 6. Recent ( 3 months) participation in a clinical study 7. History of major chronic hepatic, cardiovascular, neurological or immunosuppressive conditions or the presence of any infections 8. Patients with a risk of Deep Vein Thrombosis (DVT) as depicted by a score of >=3 on the Wellâ??s questionnaire 9. Patients with localized trauma to the lower limb 10. Dermatological conditions affecting the lower limb 11. History of skin irritation on application of bandages/tapes 12. A psychiatric condition, chronic alcohol or drug abuse problem as evidenced by withdrawal symptoms 13. Patients otherwise judged by the investigator to be inappropriate for inclusion in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Pain - Visual analogue scale (VAS) 2.Time up-and-go test, Patientsâ?? and Investigator global assessment 3.Unilateral anterior reach test. 4.Medial step-down testTimepoint: At Day 0,Day 3,Day 6,Visit 5,Day 8,Day 11 and Day 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| noneTimepoint: none | — |
Countries
India
Contacts
Public ContactDr Navneet Sonawane
Vedic Lifesciences Pvt Ltd
Outcome results
None listed